GovChime
AWARDPURCHASE ORDEROther than small business

Purchase order 75F40120P00214THE PHARMA LETTER LIMITED

Overview

Award facts

Net obligations
$113.01K
$113,008of $113.01K potential value
Outlays (paid to date)
$71.08K
$71.08K paid of $113.01K obligated$71,082
Period of performance
May 20, 2020 to May 20, 2025
Ended
Modifications
5
Latest action Apr 24, 2024
Contract type
Purchase order
PIID 75F40120P00214

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

PHARMACEUTICAL SUBSCRIPTION FOR 25 USERS

Dates and value

Award date
Signed on May 20, 2020
Potential end of performance
May 19, 2025
Current value
$113,008Base and exercised options
Potential value (if all options are exercised)
$113,008

Obligations by fiscal year of action

  • FY2024: $24,858
  • FY2023: $23,676
  • FY2022: $22,548
  • FY2021: $21,475
  • FY2020: $20,451

Total across 5 fiscal years: $113,008

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 24, 2024. View on USAspending

Recipient

NameTHE PHARMA LETTER LIMITED
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationLimited liability companyCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Foods; Human drugs; Devices and radiological health; Fda other activities (fda headquaters); Animal drugs and feed; Biologics; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Silver Spring, Maryland

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
4

Solicitation and notices

Solicitation ID
FDA-20-RFQ-1222268
Solicitation date
Jan 23, 2020
Notices

Contract details

Subcontracting plan
Plan not requiredB
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
May 20, 2020Base obligation at award: $20,451
Latest action
Apr 24, 2024 — Option exercisedModification P00005; obligation change +$24,858
Latest substantive action
Apr 24, 2024 — Option exercisedModification P00005; obligation change +$24,858
Actions by type
  • Base award1
  • Option exercised4
  • Other administrative action1
6 actions recorded, May 20, 2020 to Apr 24, 2024; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$24,858

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Meets requirementsA
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business not incorporated in the U.S.D
Country of product or service origin
United kingdomGBR
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Purchase orderB
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
6

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2020/2020-0600-000
  • 075-2021/2021-0600-000
  • 075-2022/2022-0600-000
  • 075-X-0600-000
Object classes
  • 25.2: Other services from non-Federal sources
  • 25.3: Other goods and services from Federal sources
  • 25.7: Operation and maintenance of equipment
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression